AXIOM Process Combines 3D Printing with Injection Molding, Prompted by COVID-19 Needs
The COVID-19 pandemic has changed the world as we once knew it in many ways, beginning with renewed value for good health and not sweating the small stuff; however, for those who have been affected by coronavirus, the story is much different. Known to be a frightening experience even for individuals who may be considered to be in good shape, this potentially life-threatening virus often means hospitalization. As beds in hotspot areas like New York have filled to capacity, the shortage for personal protection equipment (PPE) has been well-known, and widespread.
While medical users and the open-source community around the world have been extremely resourceful in 3D printing much-needed medical devices like ventilators, companies like Hybrid Manufacturing Technologies have stepped up to produce the volumes needed in the US for PPEs. The Mckinney, Texas-headquartered manufacturer has announced development of a new technique called AXIOM, combining 3D printing with injection molding.
The benefits of 3D printing continue to be discovered—and expanded upon—within the medical realm. Sometimes, though, the combination of traditional and progressive technologies can be extremely effective for making necessary components. The AXIOM (Automated eXtrusion Into an Open Mold) process is accompanied by the AMBIT™ XTRUDE head in a milling machine.
Although 3D printing enthusiasts currently enjoy advantages such as affordability and accessibility in hardware, software, and materials, injection molding is still often the first choice for users seeking better surface finish and quality in parts. 3D printing may also be beneficial for low-volume production, but fabrication of large quantities may not always be realistic—especially in comparison to molding.
“These factors have been highlighted in recent efforts to address PPE shortages arising with the COVID-19 pandemic,” stated the Hybrid Manufacturing Technologies team in a recent press release.
The AXIOM process works in three steps: mill, fill, and finish. This allows for plastic parts like face shields to be fabricated quickly during sudden surges and peak demand from the medical community, especially during a viral pandemic. It takes less than one minute to produce a polypropylene part, with smooth surfaces for easy sterilization—a critical requirement in the medical setting.
“We have brought together 3D printing, machining, and molding in a new way to supplement supply chains as demand surges. This means producing polymer parts without layers or the surface roughness associated with 3D printing at speeds approaching injection molding.” said Dr. Jason Jones, CEO, Hybrid Manufacturing Technologies.
These parts have not been tested for any regulatory compliance. As such, use of this design and/or process is done at your own risk.
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.
[Source / Images: ‘Hybrid Manufacturing Technologies’]
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
You May Also Like
New Business: Temporary, Migratory, & Modular 3D Printed Architecture
If we look at potentially emerging 3D printing businesses, then architecture has not been fully explored. Yes, there is a lot of house 3D printing going on worldwide. From deployable...
3D Printing News Briefs, April 19, 2025: Material Extrusion Standard, Metal Powder, & More
In today’s 3D Printing News Briefs, we’re covering a proposed standard for material extrusion, before moving on to business and metal powder. We’ll end with a commercial store’s robotic 3D...
Japan Unveils World’s First 3D Printed Train Station
Japan is now home to what we believe is the world’s first train station built with 3D printing technology. Located in Arida City, just south of Osaka, the new Hatsushima...
restor3d Raises $38M to Expand 3D Printed Orthopedic Implants
Backed by $38 million in new funding, restor3d is pushing ahead with the launch of four personalized implant lines, set to roll out in 2025 and 2026. This latest venture...